Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran
Top Cited Papers
Open Access
- 30 October 2003
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 349 (18) , 1713-1721
- https://doi.org/10.1056/nejmoa030104
Abstract
For many patients with venous thromboembolism, secondary prevention with vitamin K antagonists is not extended beyond six months, since the risk of recurrence may be outweighed by the risk of major bleeding.Keywords
This publication has 21 references indexed in Scilit:
- Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous ThromboembolismNew England Journal of Medicine, 2003
- Ximelagatran versus warfarin forstroke prevention in patientswith nonvalvular atrial fibrillation: SPORTIF ii: a dose-guiding, tolerability, and safety studyJournal of the American College of Cardiology, 2003
- Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous ThromboembolismNew England Journal of Medicine, 2003
- A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE IJournal of Thrombosis and Haemostasis, 2003
- Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous ThrombosisNew England Journal of Medicine, 2001
- A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous ThromboembolismNew England Journal of Medicine, 1999
- The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous ThromboembolismNew England Journal of Medicine, 1997
- A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein ThrombosisNew England Journal of Medicine, 1996
- A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous ThromboembolismNew England Journal of Medicine, 1995
- A prospective study of the incidence of deep‐vein thrombosis within a defined urban populationJournal of Internal Medicine, 1992